A Phase 2, Single-Arm Study to Evaluate the Safety and Pharmacokinetics of Alefacept in Adolescent Subjects with Moderate to Severe Psoriasis

To establish the safety of alefacept when administered to adolescent subjects with moderate to severe psoriasis